Metformin adverse event profile: a pharmacovigilance study based on the FDA Adverse Event Reporting System (FAERS) from 2004 to 2022

Post time 3 day(s) ago

journal：Expert Review of Clinical Pharmacology

Authors：Yikuan Du; Jinfeng Zhu; Zhuoming Guo; Zhenjie Wang; Yuni Wang; Mianda Hu; Lingzhi Zhang; Yurong Yang; Jinjin Wang; Yixing Huang; Peiying Huang; Mianhai Chen; Bo Chen; Chun Yang

Published date：2024-2-

DOI：10.1080/17512433.2024.2306223

PDF link：https://www.tandfonline.com/doi/pdf/10.1080/17512433.2024.2306223

Article link：https://doi.org/10.1080/17512433.2024.2306223

Article Source：Informa UK Limited。

Remark：

Post time 3 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Taylor&Francis] Metformin adverse event profile: a pharmacovigilance study based on the FDA Adverse Event Reporting System (FAERS) from 2004 to 2022

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Taylor&Francis] Metformin adverse event profile: a pharmacovigilance study based on the FDA Adverse Event Reporting System (FAERS) from 2004 to 2022 Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Taylor&Francis] Metformin adverse event profile: a pharmacovigilance study based on the FDA Adverse Event Reporting System (FAERS) from 2004 to 2022